B. Riley Expects Weaker Earnings for Corbus Pharmaceuticals
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Free Report) – Investment analysts at B. Riley cut their Q2 2025 earnings estimates for Corbus Pharmaceuticals in a research report issued on Tuesday, May 6th. B. Riley analyst K. Patel now expects that the biopharmaceutical company will post earnings per share of ($1.63) for the quarter, down from […]
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Free Report) – Investment analysts at B. Riley cut their Q2 2025 earnings estimates for Corbus Pharmaceuticals in a research report issued on Tuesday, May 6th. B. Riley analyst K. Patel now expects that the biopharmaceutical company will post earnings per share of ($1.63) for the quarter, down from […]
